Efficacy and Safety of a New Formulation of Pancrelipase (Ultrase MT20) in the Treatment of Malabsorption in Exocrine Pancreatic Insufficiency in Cystic Fibrosis

Background. Pancreatic enzyme replacement therapy is the standard of care for treatment of malabsorption in patients with cystic fibrosis (CF) and exocrine pancreatic insufficiency (PI). Aim. To evaluate efficacy and safety of a new formulation of pancrelipase (Ultrase MT20) in patients with CF and...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Konstan, Michael W., Liou, Theodore G., Strausbaugh, Steven D., Ahrens, Richard, Kanga, Jamshed F., Graff, Gavin R., Moffett, Kathryn, Millard, Susan L., Nasr, Samya Z., Siméon, Édith, Spénard, Jean, Grondin, Josée
Natura: Artigo
Lingua:Inglês
Pubblicazione: Hindawi Publishing Corporation 2010
Soggetti:
Clinical Study
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3004382/
https://ncbi.nlm.nih.gov/pubmed/21197074
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2010/898193
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi